PA

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mease PJ et al. - The findings support a positive risk/benefit profile for duloxetine in the long-term treatment of fibromyalgia.

Related Articles

Changes in Hippocampal Metabolites After Effective Treatment for Fibromyalgia: A Case Study
The Clinical Journal of Pain, 10/20/09    Relevance Score: 94%

Womens narratives on experiences of work ability and functioning in fibromyalgia
Musculoskeletal Care, 10/23/09    Relevance Score: 93%

General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study
BMC Public Health, 11/04/09    Relevance Score: 90%

Fibromyalgia: From treatment to rehabilitation
European Journal of Pain, 11/17/09    Relevance Score: 89%

Are chronic fatigue syndrome and fibromyalgia the same? Implications for the provision of appropriate mental health intervention
Journal of Psychiatric and Mental Health Nursing, 11/16/09    Relevance Score: 89%

Today in Clinical Pharmacology...keeping you current

Sex-Based Differences in Drug Activity
American Family Physician, 12/03/09

Dermatomyositis: current and future treatments
Expert Review of Dermatology, 12/03/09

Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview
Journal of the European Academy of Dermatology and Venereology, 12/03/09

Today in Rheumatology...keeping you current

Dermatomyositis: current and future treatments
Expert Review of Dermatology, 12/03/09

Somatosensory conflicts in complex regional pain syndrome type 1 and fibromyalgia syndrome
Current Rheumatology Reports, 12/03/09

Hypocomplementemic urticarial vasculitis syndrome
Current Rheumatology Reports, 12/03/09